Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2000
09/28/2000WO2000056769A2 COMPOSITIONS, TEST KITS AND METHODS FOR DETECTING $i(HELICOBACTER PYLORI)
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056764A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056753A1 49 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056748A1 Xylo-lna analogues
09/28/2000WO2000056681A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
09/28/2000WO2000056443A1 Device and method for applying micro-droplets on a substrate
09/28/2000WO2000056442A1 Fluids manipulation device with format conversion
09/28/2000WO2000056405A2 Human tumor necrosis factor receptor-like 2
09/28/2000WO2000056357A2 Staphylococcus antigen and vaccine
09/28/2000WO2000056355A1 Phytofluors as fluorescent labels
09/28/2000WO2000056352A2 Reagents and methods useful for detecting diseases of the prostate
09/28/2000WO2000056333A1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance
09/28/2000WO2000056208A1 Biopsy needle instrument
09/28/2000WO2000056144A1 Human sperm surface antigen
09/28/2000WO2000056135A2 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
09/28/2000WO2000041610A3 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000041497A3 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
09/28/2000WO2000031253A3 Mutation of the parkin gene, compositions, methods and uses
09/28/2000WO2000029817A9 Self-diagnostic system for conditioned maintenance of machines operating under intermittent load
09/28/2000WO2000029577A9 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
09/28/2000WO2000028332A9 Methods and compositions to lower plasma cholesterol levels
09/28/2000WO2000028071A9 A method for the determination of homocysteine
09/28/2000WO2000026638A9 Methods of use for sensor based fluid detection devices
09/28/2000WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49
09/28/2000WO2000025807A9 Binding moieties for human parvovirus b19
09/28/2000WO2000023801A9 System for applying controlled pressure profiles to biological samples and methods relating thereto
09/28/2000WO2000023576A3 Secretases related to alzheimer's dementia
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000020438A9 G protein-coupled receptor resembling the thrombin receptor
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000WO2000009464A9 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
09/28/2000WO2000007013A3 Analyte test instrument system including data management system
09/28/2000WO1999067417A3 Fitness assay and associated methods
09/28/2000DE19914037A1 Hygieneartikel zum einmaligen Gebrauch Sanitary Products for single use
09/28/2000DE19913858A1 High-Throughput-Screening-Verfahren zur Bestimmung der Enantioselektivität asymmetrisch verlaufender Reaktionen High-throughput screening method for determining the enantioselectivity of asymmetric extending reactions
09/28/2000DE19913428A1 Verwendung von Kollagenase 3 zum Nachweis von destruktiven Gelenkerkrankungen, insbesondere zur Prognose des Krankheitsverlaufs und zur genetischen Prädisposition der Rheumatoiden Arthritis (RA) Use of collagenase 3 for detecting destructive joint diseases, in particular for prognostic and genetic predisposition of rheumatoid arthritis (RA)
09/28/2000DE19911869A1 Detection of gases or vapors in air involves using a sensor element having a gas sensitive layer and heated by using an electric heater
09/28/2000DE19910956A1 Determining sensitivity of cells to apoptotic agents, useful e.g. for selecting compounds for treating cancer, by measurement of accumulated caspase activity
09/28/2000DE19910955A1 Determining sensitivity of cells to apoptotic agents, useful e.g. for selecting compounds for treating cancer, using externalization of phosphatidyl serine as apoptotic marker
09/28/2000DE19910354A1 Detecting viral infection of germ cells, useful e.g. for isolating ova or sperm suitable for in vitro fertilization and for detecting male infertility
09/28/2000DE19850350C1 Verfahren und Vorrichtung zur Erzeugung von Daten für die Diagnose des Schädigungsgrades von Hautgewebe eines Patienten Method and apparatus for generating data for the diagnosis of the degree of damage to skin tissue of a patient
09/28/2000DE10014335A1 Determining gaseous emissions from surfaces comprises inducing additional gas emissions of the gas to be determined on, in or under the surface to be investigated and collecting a gas sample using a system installed above the surface
09/28/2000CA2814831A1 Hyphal growth in fungi
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2377383A1 Apoptosis related genes
09/28/2000CA2371987A1 Screening method involving mgdg synthase
09/28/2000CA2368916A1 49 human secreted proteins
09/28/2000CA2368548A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2367857A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367471A1 Fungal beta-tubulin genes
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
09/28/2000CA2367125A1 Reagents and methods useful for detecting diseases of the prostate
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366676A1 Biopsy needle instrument
09/28/2000CA2366663A1 Method for quantitating cholesterol
09/28/2000CA2366555A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000CA2366552A1 Method for detecting superantigen activity in a biological sample
09/28/2000CA2366289A1 Solution-based methods and materials for sequence analysis by hybridization
09/28/2000CA2366267A1 49 human secreted proteins
09/28/2000CA2366249A1 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
09/28/2000CA2366237A1 Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
09/28/2000CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2366080A1 Prediction of diabetes impaired wound healing by urinary nitrate assay
09/28/2000CA2365981A1 Linear and circular expression elements
09/28/2000CA2365405A1 Human tumor necrosis factor receptor-like 2
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365184A1 Masterbatches having high levels of resin, in particular for modifying polymers
09/28/2000CA2365121A1 Antibodies specific for cyp1b1
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2364607A1 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
09/27/2000EP1039299A1 A method of detecting protein and a kit using the same
09/27/2000EP1039298A2 Multilayer analytical test element
09/27/2000EP1039297A1 Reagent for the determination of leucocytes and the measurement of hemoglobin in a blood sample
09/27/2000EP1039296A1 System for measuring coagulation of bodily fluids
09/27/2000EP1039295A2 System for measuring the coagulation of body fluids
09/27/2000EP1039294A2 A method and apparatus for the analysis of a liquid carrying a suspension of organic matter
09/27/2000EP1039293A1 Method for inspecting electrochemical gas sensor
09/27/2000EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae
09/27/2000EP1038939A1 Chemiluminescent reagents and chemiluminescence analysis methods with the use of the same
09/27/2000EP1038876A2 1,2-Dioxetane derivative fused to pyran ring and use thereof
09/27/2000EP1038523A2 Method for identifying compounds for inhibition of neoplastic lesions
09/27/2000EP1038183A1 Method to identify transcriptional modulators
1 ... 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 3082 3083 3084 3085 3086 3087 3088 3089 3090 ... 3937